Connect With ProSciento at the European Association for the Study of the Liver Congress 2025
Schedule a meeting with ProSciento at the European Association for the Study of the Liver (EASL) Congress to discover how our science-driven methodologies, specialized site support services, and commitment to biomarker discovery can transform your clinical trials.
As the leading clinical research organization (CRO) focused on diseases across the metabolic continuum, ProSciento is dedicated to advancing research and therapeutic development with unmatched expertise in steatotic liver diseases, obesity, and diabetes.
Our team of science-driven experts understands the complexities of metabolic diseases and their interconnectedness, enabling sponsors to address the challenges of these multifaceted conditions. We meticulously design and conduct patient-focused strategies that deliver actionable insights, accelerate clinical research, and improve health outcomes.
Together, we can bring better treatments to patients and advance the future of metabolic disease therapeutics.
